Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Buzz on the Bullboards: Competition Heats Up in Top Sectors

(Image via HEXO Corp.) It can be hard to keep track of the news cycle, but you can bet the markets are going to be more volatile. That has been the case this autumn trading season so far, and October does not seem to be letting up anytime soon. The Stockhouse Bu...

Novavax Announces Its First-in-Human Coronavirus Vaccine Trial Will Begin in Mid-May

Shares of Novavax traded 20% higher setting a new 52-week high price after the company reported that it has accelerated initiation of a Phase 1 clinical trial for its coronavirus vaccine candidate NVX-CoV2373. The study will commence in mid-May with preliminary results expec...

Novavax Shares Rise 9% Upon Initiating Phase 1/2 COVID-19 Vaccine Clinical Trial

Novavax shares traded higher after the company reported it enrolled the first participants in its Phase 1 clinical study of NVX CoV2373. Novavax Inc. (NVAX:NASDAQ) , which focuses its efforts on developing next-generation vaccines to address infectious diseases, ye...

Allakos Shares Double on AK002 Phase 2 Results and Earnings

Allakos Inc. shares are soaring today as the company reported Q2/19 earnings and announced positive results from its phase 2 study for its AK002 inhibitor used in the treatment of eosinophil and mast cell related diseases. Clinical stage biotech company Allak...

Buzz on the Bullboards: Stocks Making the Most of the Summer

(Image via Inter Pipeline Ltd.) After a few tumultuous weeks of see-sawing market performances on Bay Street and Wall Street, it would appear as if companies were working to get on track to get back to the seasonably busy fall months and shake off these COVID restri...

Buzz on the Bullboards: The Top Last-Minute Movers of 2021

Expecting the markets to be relaxed heading into the holidays? Hardly. Many investors and brokers know that this is the time to shine. With every twist and turn the global economy has been throwing our way, the right move is staying active. This past week, it seems ma...

Buzz on the Bullboards: T’is the Season for a Rebound?

(Image via SweetWater Brewing Co.) It happens every year, the mood among North American markets changes drastically once American Thanksgiving passes and despite a “socially distanced” holiday this year, that still holds true. Traders are ...

XPhyto: Is Mescaline the Next Big Mood-Modifying Medicine?

It has the potential to be the next frontier in the psychedelics renaissance, and it represents an unprecedented opportunity to innovate a notable advancement in mental health therapy. In anecdotal studies, mescaline has shown promise in treating depression, anxiety, PTSD,...

Robust Gold, Silver Projects & Promising Drill Results

(Click to play video.) Affinity Metals Corp. ( TSX-V: AFF , Forum ) is focused on the acquisition, exploration, and development of strategic metal deposits within North America. Affinity is following a hybrid approach of combining the advancement of stra...

Buzz on the Bullboards: Rapid growth, or mild swelling?

It has been another rocky week for North American markets as traders continue to weigh the risks of inflation and the health of the financial sector. Canada’s own main stock index recently hit a two-week low, but in the face of every performance in the red...
1 2 3 4 5 6 7 8 9 10 ...